New copolymeric polycondensation products between 1,10-bis(2-hydroxyethylthio)decane, poly(oxyethyleneglycol)s or poly(oxypropyleneglycol)s, and bis(carboxylic acid)s

Abstract

 A new series of oligomeric or polymeric compounds having a poly(ester) structure, wherein the monomeric starting materials are 1,10-bis(2-hydroxyethy(thio)decane, poly(oxy- ethyleneglycol)s or poly(oxypropyleneglycol)s and carboxylic acids, the process for the preparation thereof and the therapeutic use thereof.

Description

[0001] The present invention refers to a new series of copolymeric poly(ester)s having the following struc ture:

wherein the meanings of n, x, y, z, _R, _R , _R², X, _Y are the following:

n is an integer ranging from 0 to 100

x and y are integers ranging from 1 to 100

z is an integer equal to (x + y)

R and _R¹ may be either H or CH₃, with the exclusion of the case in which both are CH₃

R2 is an organic biradical to which two carboxylic groups may be connected

X may be either H or

where R² is the sa-me as within parentheses

Y may be OH, or O-CH₂CH₂-S-(CH₂)₁₀-S-CH₂CH₂-OH, or

where n, R and R¹ are the sa

[0002] as within the square parentheses.

[0003] A further definition of the above formula is, that each unit labelled z is preceeded and followed by a unit labelled x or y; each unit labelled z or y is preceeded and followed by a unit labelled z; but in no case a unit labelled x may be preceeded or followed by a unit labelled y, and vice-versa. The distribution of units labelled x and y with regard each other along the polymeric chain may be either random, or alternating, according to the synthetic method employed.

[0004] Thus, the present invention relates a series of new oligomeric or polymeric products having a poly(ester) structure, in which Thiadenol, poly(oxyethylenegly- col)s or poly(oxypropyleneglycol)s, and dicarboxylic acids are the starting monomeric materials.

[0005] It is well known that 1,10-bis(2-hydroxyethyl- thio)decane, commonly marketed as Thiadenol, is a widely used hypolipemizing drug, active in several types of dislipidemy. This drug, however, has some serious drawbacks, which are mainly related to a too fast rate of metabolism and excretion. Large daily doses, and repeated administrations are usually needed, the recommended treatment usually involving three 0.8 g administrations a day, totalling 2.4 g. This daily dose may be reduced after some time to about 1.8 g/day. Such large doses often induce gastric pains, nausea, and vomit. Thiadenol is not recommended when the patient has some previous records of gastritis, or gastric or duodenal ulcera.

[0006] The object of the present invention is to overcome most of the above drawbacks connected with the use of free Thiadenol.

[0007] It may be observed that in the above products the active principle is bound to a polymeric structure by ester bonds. This may ensure a gradual release of the drug into the body fluids, since ester bonds can be hydrolised in biological environments. This can lead to a more prolonged activity, and unfavoura ble side-effects due to hyperdosage can be minimized.

[0008] The introduction of poly(oxyethyleneglycol) or poly(oxypropyleneglycol) moieties is of advantage for the following reasons:

1) it imparts to the polycondensates a degree of hydrophilicity which facilitates the hydrolysis of the ester bonds;

2) in the case of low molecular weight polymers, it fa cilitates the adsorption through the gastrointestinal tract.

[0009] The synthesis of the above polymers may be performed by heating a mixture of 1,10-bis(2-hydroxyethyl thio)decane and a poly(oxyethyleneglycol) or poly(oxy propyleneglycol) with a bis-carboxylic acid, preferably in the presence of a suitable catalyst, and elimi nating water which is formed as polyesterification proceeds.

[0010] Instead of the free acids, reactive derivatives of the same acids can be employed, such as for instance their anhydrides, chlorides, or reactive esters and amides (imidazolides, benzotriazolides and the like). By this way, random copolymers can be obtained (see above).

[0011] Another way to obtain the title polymers, leading to products in which Thiadenol-deriving groups and poly(oxyethyleneglycol) or poly(oxypropyleneglycol) groups alternate along the polymeric chain, is the following. First of all, a hemiester of poly(oxy- ethyleneglycol) or poly(oxypropyleneglycol) with a bis-acid is prepared, according to known methods (see e.g.: P. Ferruti et al., Makromoleculare Chemie, vol. 182, pag. 2183, 1981; L. Rusconi, M.C. Tan zi, C. Zambelli, P. Ferruti, Polymer, Vol. 23, pag. 1689, 1982).

[0012] Thereafter a reactive derivative of the same is prepared, which is finally reacted with Thiadenol, according to the following Scheme, in which imidazolides are choosen as reactive derivatives:

[0013] Alternatively, starting from Thiadenol, the hemiester may be prepared, from which the bis-imidazolide is subsequently obtained, which is finally treated with an excess of poly(oxyethyleneglycol) or poly(oxypropyleneglycol).

[0014] As far as the dicarboxylic acids are concerned, any aliphatic, cycloaliphatic, aromatic, and heterocyclic dicarboxylic acid can be used, as it is apparent to every experienced organic chemist, provided no other chemical functions are present which are able to interfere in the polycondensation process. Usually, however, we preferred to use, as monomers, bis-acids which are commonly found in living organisms, such as for instance succinic acid, glutaric acid, adipic acid, sebacic acid, and the like, in or der to avoid the production of toxic fragments after the hydrolytic breakdown of the polymeric product in the body fluids. On this respect, may be worthy to mention that poly(oxyethyleneglycol)s and poly(oxypropyleneglycol)s, also introduced as comonomers, are known to have a very reduced toxicity, and are commonly used in syrups and other pharmaceu tical compositions.

[0015] The acute toxicity of the products, in all the tested cases, was found to be very low. Their LD ₅₀ in rats, and rabbits, could be hardly determined, in any case being higher than 1,000 mg/kg.

[0016] In order to better elucidate the above disclosure, the following non-limitative Examples are given by way of illustration.

EXAMPLE 1

[0017] Glutaric anhydride (10.42 g, 0.09 mole), 1,10- bis(2-hydroxyethylthio)decane (i.e. thiadenol, 17.67 g, 0.06 mole), triethyleneglycol (9.01 g, 0.06 mole), and toluene (500 ml) were charged into a 1 li ter flask equipped with a Sohlet apparatus filled with a suitable dehydrating agent (silica or calcium sulfate). 4-Toluensulfonic acid (1.0 g) was added as the catalyst,and the mixture was refluxed for 48 hrs, the water formed during esterification being continuously removed with toluene, and captured by the dehydrating agent while passing through the Soxhlet apparatus.

[0018] After this time, the reaction mixture was treated with decolourising carbon (3 g), filtered, and evapo rated to dryness "in vacuo". The residue was then treated with methanol (200 ml), refluxed 2 m, cooled to O°C, and decanted. This treatment was repeated three times. The final residue was dried to constant weight at 90°C and 0.1 Tor. Yield 17.5 g.

[0019] The product was a 70/30 mixture of two polymers, the first of which (A) contained for each molecule 3 glutaric anhydride moieties, 3 Thiadenol moieties, and 1 triethyleneglycol moiety, while the other one (B) contained 3 glutaric anhydride moieties, 3 triethyleneglycol moieties, and 1 Thiadenol moiety. The average molecular weight of this mixture is 1262; found (by vapour pressure osmometry) 1277. Analysis: calculated C 57.55%, H 8.45%;
found C 57.50%, H 8.66%. ¹_H-_NMR spectroscopy gave results in full agreement with the above structure. The two compounds could be separated by normal fractionation techniques, using toluene as the solvent, and methanol as the nonsolvent.

[0020] It may be noticed that product A corresponds to the general formula given in the text, where n = 2, x = 1, y = 3, z = 3, R = R¹ = H, R² = -(CH₂)₃-, ^X = H, U = -O-CH₂CH₂-S-(CH₂)₁₀-S-CH₂CH₂-OH; while in product B n = 2, x = 3, y = 1, z = 3, R = R = H, R² = -(CH₂)₃-, X ^{= H, Y =}

where _R, _R¹, and n have the same meanings as above.

EXAMPLE 2

[0021] The same procedure as in Example 1 was followed, by substituting adipic acid (0.09 mole) and poly-(propyleneglycol) having molecular weight 400 (0.06 mole) for equimolecular quantities of glutaric anhy dride and triethyleneglycol. The raw product was isolated in the same way, to yield 24 g. It was a 75/25 mixture of two products (A and B), which could be separated by fractionation as indicated above. Product A corresponds to the formula of the Text, whe re n = 6, x = 1, y = 2, z. = 3, R = H, R¹ = CH₃ (or vice-versa, R = CH and R¹ = H), R² = -(CH₂)₄-, X = H, Y = -O-CH₂CH₂-S-(CH₂)₁₀-S-CH₂CH₂-OH; while in product B n = 6, x = 2, y = 1, z = 3, R = H, R¹ = CH₃ (or vice-versa, R = CH and R¹ = H), R² = -(CH₂)₄-,

where, as usual, R, R^-, and n are the same as above. EXAMPLE 3 The same procedure as in Example 1 was followed, by substituting tetraethyleneglycol (0.06 mole) for an equimolecular quantity of triethyleneglycol. Yield 21 g. The product was a 70/30 mixture of two products A and B, having the same structures of products A and B of Example 1, apart form the meaning of n, which is 3 instead of 2.

EXAMPLE 4

[0022] Poly(oxyethyleneglycol) hemisuccinate (obtained starting from poly(oxyethyleneglycol) of molecular weight 1000, for instance as described in P. Ferruti et al., Makromoleculare Chemie, Vol. 182, pag. 2183, 1981), (12 g, 0.01 mole), was dissolved in anhydrous, alcohol-free chloroform (100 ml). N,N'- carbonyldiimidazole (1.62 g, 0.01 mole) was added, and the mixture stirred at room temperature for 30'. 1,10-Bis(2-hydroxyethylthio)decane (3.234 g, 0.011 mole) was then added, and the mixture was maintained at 60°C for 48 hrs. Great care must be exercised to exclude moisture at every stage of the process. After this time, the reaction mixture was diluted with chloroform (200 ml), and extracted with 3 x 100 ml portions of 0.5 M aq. hydrochloric acid, then with 3 x 100 ml portions of water. The organic layer was finally dried (Na₂SO₄), evaporated in vacuo to one-fourth of its original volume, and poured into 400 ml of ether. The product was decanted, and dried to constant weight at 50°C and 0.1 Torr. Yield 13.6 g. All analytical data agreed with a structure corresponding to the general formula of the Text, in which n = 21, x = 9, y = 9, z = 18, R = R¹ = H, R² = -(CH₂)₂-, X = H, ^{Y =} -O-CH₂CH₂-S-(CH₂)₁₀-S-CH₂CH₂-OH, and in which the units x and y had a regular alternance along the macromolecular chain, being connected by succinoyl moieties.

Claims

CLAIMS for the Contracting States: BE, CH, DE, FR, GB, IT, LI, LU, NL, SE

1. Oligomeric or polymeric compounds having the structure of co-poly(ester)s, in which the alcoholic moieties derive from 1,10-bis(2-hydroxyethyl- thio)decane and a poly(oxyethyleneglycol) or poly-(oxypropyleneglycol), in various ratios, and the acidic moieties derive from dicarboxylic acids, of general formula

wherein:

n is an integer ranging from O to 100

x and y are integers ranging from 1 to 100

z is an integer equal to (x + y)

R and R¹ may be either H or CH₃, with the exclusion of the case in which both are CH₃

R² is an organic biradical to which two carboxylic groups may be connected

X may be either H or

where R has the above mentioned meanings

Y may be -OH, or -O-CH₂CH₂-S-(CH₂)₁₀ S-CH₂CH₂-OH, or

where n, R and R^┴ h_a- ve the above mentioned meanings.

2. Compounds according to claim 1, wherein ^R2 is -(CH2)2-, -(CH₂)₃-, -(CH₂)₄-, or cycloaliphatic hydrocarbon diradicals.

3. Compounds according to claims 1-2, wherein _R² is any other organic diradical, provided it does not contain chemical functions which affect negatively the polyesterification process.

4. A process for the preparation of compounds according to claims 1-3, characterized in reacting 1,10-bis(2-hydroxyethylthio)decane, poly(oxyethyle- neglycol)s and/or poly(oxypropyleneglycol)s, and di carboxylic acid reactive derivatives, such as their anhydrides, imidazolides, chlorides, and the like.

5. A process for the preparation of compounds according to claims 1-3, characterized in reacting the bis-hemiester of a poly(oxyethyleneglycol) or poly-(oxypropyleneglycol) with a dicarboxylic acid, activating the residual carboxylic groups of the se derivatives, and reacting these reactive derivatives with 1,10-bis(2-hydroxyethylthio)decane.

6. Pharmaceutical compositions having hypolipemizing activity containing, as the active ingredient, at least one compound according to claims 1-3.

CLAIMS for AT

1. A process for preparing oligomeric or polymeric compounds having the structure of co-poly-(ester)s, in which the alcoholic moieties derive from 1,10-bis((2-hydroxyethylthio)decane and a poly(oxyethyleneglycol) or poly(oxypropyleneglycol), in various ratios, and the acidic moieties derive from dicarboxylic acids, of general formula

wherein:

n is an integer ranging from O to 100

x and y are integers ranging from 1 to 100

z is an integer equal to (x + y)

R and R¹ may be either H or CH₃, with the exclusion of the case in which both are CH₃

_R² is an organic biradical to which two carboxylic groups may be connected

X may be either H or

where R 2 has the above mentioned meanings

Y may be -OH, or -O-CH₂CH₂-S-(CH₂)₁₀-S-CH₂CH₂-OH, or

where n, R and _R¹ h_a-

ve the above mentioned meanings, characterized in reacting 1,10-bis(2-hydroxyethyl- thio)decane, poly(oxyethyleneglycol)s and/or poly-(oxypropyleneglycol)s, and dicarboxylic acid reactive derivatives, such as their anhydrides, imidazolides, chlorides, and the like.

2. A process for preparing compounds of claim 1, characterized in reacting the bis-hemiester of a poly(oxyethyleneglycol) or poly(oxypropyleneglycol) with a dicarboxylic acid, activating the residual carboxylic groups of these derivatives, and reacting these reactive derivatives with 1,10-bis(2-hydroxy- ethylthio)decane.